Fundraising Fox

Rx Redefined

Arroyo Grande, US · Founded 2017 · Delaware corporation · 4 known investors

rxredefined.com ↗

Rx Redefined operates a patented technology platform that lets physicians directly manage the distribution of medical supplies—such as insulin pumps, breast pumps, ostomy pouches, and urinary catheters—to their patients, removing intermediaries. It serves medical practices and their patients in the U.S., aiming to reduce care gaps and lower supply utilization compared to traditional delivery pathways.

BiotechDigital HealthHealthtechMedical Devicesin /rxredefined

Founders & leadership

BB
Brandon BootsFounder & CEO
ES
Erik SmithExecutive Officer, Director
IC
Ian ChiangDirector
RC
Roger ChenDirector

Investors · 4

Crosscut VenturesLos Angeles · $250K – $750K
Flare Capital PartnersBoston · $1M – $10Mvia Ian Chiang · board
Silverton PartnersAustin · $200K – $2M
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M

Reported raises · per SEC filings

Form D private placements
▶$21.5MraisedDec 2024 · 8 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon BootsExecutive Officer, Director, Promoter
  • Ian ChiangDirector
  • Roger ChenDirector
  • Erik SmithExecutive Officer, Director
Offering amount
$24M
Amount sold
$21.5M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedSep 2022 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Erik SmithDirector
  • Brandon BootsExecutive Officer
  • Roger ChenDirector
Offering amount
$8M
Amount sold
$8M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJun 2021 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Roger ChenDirector
  • Erik SmithExecutive Officer, Director
  • Brandon BootsExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.2MraisedJun 2021 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon BootsExecutive Officer, Director
  • Roger ChenDirector
  • Erik SmithExecutive Officer, Director
Offering amount
$3.2M
Amount sold
$3.2M
First sale
May 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.